Medtronic Pays $12M To 5 States For Deceptive Marketing Of Infuse Bone Graft
BOSTON — Medtronic Inc. has agreed to pay $12 million to five states to resolve allegations that it engaged in deceptive marketing of the company’s Infuse bone graft, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article